简介：杨潇，理学博士。现为中山大学药学院博士后。主要从事药物性肝损伤与肝再生过程中线粒体机制及早期干预研究。
科研项目：
1. 中国博士后科学基金第1批特别资助（站前）
2.?中国博士后科学基金第67批面上资助
3.?中山大学青年教师培育项目，2020.01-2022.12
4. 国家自然科学基金青年项目，2021.01-2022.12
发表论文：
X. Yang, F.J. Gonzalez, M. Huang, H.C. Bi*. Nuclear receptors and non-alcoholic fatty liver disease: An update. Liver Research, 2020, 4(2).
W.Q. Wang #, X. Yang?#, Y. Chen, X. Ye, K. Jiang, A.Z. Xiong*, L. Yang*, Z.T Wang. Seneciphylline, a main pyrrolizidine alkaloid in Gynura japonica, induces hepatotoxicity in mice and primary hepatocytes via activating mitochondria-mediated apoptosis. J Appl Toxicol. 2020; 40(11):1534-1544.
X. Yang, H. Wang, H.M. Ni, A.Z. Xiong, Z.T. Wang, H. Sesaki, W.X. Ding*, L. Yang*. Inhibition of Drp1 protects against senecionine-induced mitochondria-mediated apoptosis in primary hepatocytes and in mice.?Redox Biol. 2017; 12:264-273.
X. Yang, X.J. Chao, Z.T. Wang, W.X. Ding*. The end of RIPK1-RIPK3-MLKL-mediated necroptosis in acetaminophen-induced hepatotoxicity? Hepatology. 2016; 64(1):311-2.